STOCK TITAN

Nuveen Dow 30 Dynamic Overwrite Fund (NYSE: DIAX) Delists

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
25-NSE

Rhea-AI Filing Summary

New York Stock Exchange notified removal of Common Shares of Beneficial Interest of Nuveen Dow 30 Dynamic Overwrite Fund from listing and registration under Section 12(b) of the Exchange Act.

The filing cites compliance with 17 CFR 240.12d2-2 and states the exchange and issuer followed exchange rules for voluntary withdrawal.

Positive

  • None.

Negative

  • None.
Commission File Number 001-36772 Form 25 cover reference
Expiration reference March 31, 2018 Expires line on the form
Issuer address zip 60606 Issuer principal executive offices, Chicago, ILLINOIS
Form 25 regulatory
"FORM 25 NOTIFICATION OF REMOVAL FROM LISTING"
A Form 25 is an official filing with the U.S. Securities and Exchange Commission used to remove a company's stock or other security from a national exchange list. Investors should care because delisting often means less visibility, lower trading volume and wider price swings—similar to a product moving from a major supermarket to a small local market, which can make buying, selling and valuing the security more difficult.
Section 12(b) regulatory
"REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b)"
Section 12(b) of the U.S. Securities Exchange Act requires securities listed on a national stock exchange to be registered with the U.S. Securities and Exchange Commission (SEC) and to follow regular public reporting and disclosure rules. For investors, a 12(b) listing generally means more routine financial updates, regulatory oversight and easier buying and selling—like a storefront that must display its inventory and prices, making it simpler to inspect and trade the product.
17 CFR 240.12d2-2 regulatory
"Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied"
A U.S. Securities and Exchange Commission rule that describes the conditions and procedural steps for a security to be removed from public registration or reporting under the Securities Exchange Act of 1934. For investors, it matters because it explains when a company’s shares can stop being subject to regular disclosure and exchange listing rules — similar to knowing when a publicly tracked product will be discontinued and no longer send updates, which affects transparency and liquidity.
UNITED STATES
OMB APPROVAL
OMB Number: 3235-0080
Expires: March 31, 2018
Estimated average burden
hours per response: 1.7
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-36772
Issuer: Nuveen Dow 30sm Dynamic Overwrite Fund
Exchange: NEW YORK STOCK EXCHANGE LLC
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address: 333 West Wacker Drive
Chicago ILLINOIS 60606
Telephone number:
(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
Common Shares of Beneficial Interest
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
17 CFR 240.12d2-2(a)(1)
17 CFR 240.12d2-2(a)(2)
17 CFR 240.12d2-2(a)(3)
17 CFR 240.12d2-2(a)(4)
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2026-03-30 By Tyler Mastronardi Analyst, Market Watch
Date Name Title
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Why did Nuveen Dow 30 Dynamic Overwrite Fund (DIAX) file a Form 25?

Answer: The Form 25 notifies the Exchange and SEC of removal of DIAX common shares from listing under Section 12(b). The filing states the exchange and issuer complied with 17 CFR 240.12d2-2 and exchange rules governing voluntary withdrawal.

When does the Form 25 expiration/date appear for DIAX?

Answer: The document shows an expiration reference of March 31, 2018. The filing also lists Commission File Number 001-36772 tied to the issuer's listing removal notification.

Who signed the Form 25 for the DIAX listing removal?

Answer: The Form 25 is signed on behalf of the Exchange by Tyler Mastronardi, listed with the title Analyst, Market Watch, certifying the exchange's compliance with applicable rules for the removal.

What regulatory citations are referenced in the DIAX Form 25?

Answer: The filing references 17 CFR 240.12d2-2 (subsections (a)(1)-(4), (b), (c)) and Section 12(b) of the Securities Exchange Act as the legal basis for withdrawal and strike from listing.